Compound details
4-Hydroxybenzoic acid
| Compound ID | CDAMM00347 |
|---|---|
| Common name | 4-Hydroxybenzoic acid | IUPAC name | 4-hydroxybenzoic acid |
| Molecular formula | C7H6O3 |
| Retention time | 25.425 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 139.04 | Theoretical mz | 139.039 |
| Error | 3.81 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.78 |
| Inchi key | FJKROLUGYXJWQN-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C(O)C1=CC=C(O)C=C1 |
| Superclass | Benzenoids |
| Class | Benzene and substituted derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction and SEA |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction and SEA |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction and SEA |
| P02766 | TTR | Transthyretin | T86462 | SEA |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction and SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| Q96RI1 | NR1H4 | Bile acid receptor FXR | T51426 | SEA |
| P31213 | SRD5A2 | Steroid 5-alpha-reductase 2 | T71390 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SwissTargetPrediction and SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SwissTargetPrediction and SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SwissTargetPrediction and SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SwissTargetPrediction and SEA |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SEA |
| Q9H3R0 | KDM4C | Lysine-specific demethylase 4C | T73863 | SEA |
| P23141 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | T76369 | SEA |
| P42330 | AKR1C3 | Aldo-keto-reductase family 1 member C3 | T60857 | SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SEA |
| O75164 | KDM4A | Lysine-specific demethylase 4A | T18904 | SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SEA |
| P80404 | ABAT | Gamma-amino-N-butyrate transaminase | T59045 | SEA |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SEA |
| Q07075 | ENPEP | Aminopeptidase A | T31956 | SEA |
| P08575 | PTPRC | Leukocyte common antigen | T43115 | SEA |
| P03372 | ESR1 | Estrogen receptor alpha | T02506 | SEA |
| Q9Y4C1 | KDM3A | Lysine-specific demethylase 3A | T25362 | SEA |
| P27695 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | T13348 | SEA |
| P10276 | RARA | Retinoic acid receptor alpha | T94085 | SEA |
| P41229 | KDM5C | Lysine-specific demethylase 5C | T85540 | SEA |
| Q9Y2K7 | KDM2A | Lysine-specific demethylase 2A | T71949 | SEA |
| O43174 | CYP26A1 | Cytochrome P450 26A1 | T84634 | SEA |
| P19793 | RXRA | Retinoid X receptor alpha (by homology) | T13726 | SEA |
| P62508 | ESRRG | Estrogen-related receptor gamma | T59875 | SEA |
| Q9UNI1 | CELA1 | Elastase 1 | T22839 | SEA |
| P28702 | RXRB | Retinoid X receptor beta | T60077 | SEA |
| P13631 | RARG | Retinoic acid receptor gamma | T82146 | SEA |
| P48443 | RXRG | Retinoid X receptor gamma | T46456 | SEA |
| P10826 | RARB | Retinoic acid receptor beta | T61657 | SEA |
| P22736 | NR4A1 | Nuclear receptor subfamily 4 group A member 1 | T41119 | SEA |
| P53582 | METAP1 | Methionine aminopeptidase 1 | T42337 | SEA |
| P41235 | HNF4A | Hepatocyte nuclear factor 4-alpha | T15514 | SEA |
| Q9UJM8 | HAO1 | Hydroxyacid oxidase 1 | T63170 | SEA |
| P24593 | IGFBP5 | Insulin-like growth factor binding protein 5 | T17008 | SEA |
| P24592 | IGFBP6 | Insulin-like growth factor binding protein 6 | T61800 | SEA |
| P18065 | IGFBP2 | Insulin-like growth factor binding protein 2 | T64268 | SEA |
| P08833 | IGFBP1 | Insulin-like growth factor binding protein 1 | T15048 | SEA |
| P45974 | USP5 | Ubiquitin carboxyl-terminal hydrolase 5 | T17067 | SEA |
| P51649 | ALDH5A1 | Succinate semialdehyde dehydrogenase | T13259 | SEA |
| Q9UPY5 | SLC7A11 | Cystine/glutamate transporter | T11615 | SEA |
| P13674 | P4HA1 | Prolyl 4-hydroxylasesubunit alpha-1 | T61729 | SEA |
| P49019 | HCAR3 | Hydroxycarboxylic acid receptor 3 | T00890 | SEA |
| Q04609 | FOLH1 | Glutamate carboxypeptidase II | T97071 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| P09172 | DBH | Dopamine beta hydroxylase | T74937 | SEA |
| Q9UBS0 | RPS6KB2 | Ribosomal protein S6 kinase beta-2 | T42760 | SEA |
| P43354 | NR4A2 | Orphan nuclear receptor NURR1 | T67163 | SEA |
| Q96LD8 | SENP8 | Deneddylase-1 | T13928 | SEA |
| Q9C000 | NLRP1 | NLR pyrin domain containing 1 | T86910 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T51426 | DI0043 | Autoimmune liver disease | [ICD-11: DB96] | Q96RI1 | NR1H4 |
| T51426 | DI0077 | Cholelithiasis | [ICD-11: DC11] | Q96RI1 | NR1H4 |
| T51426 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q96RI1 | NR1H4 |
| T71390 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P31213 | SRD5A2 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T76369 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P23141 | CES1 |
| T76369 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P23141 | CES1 |
| T60857 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P42330 | AKR1C3 |
| T59045 | DI0060 | Brain cancer | [ICD-11: 2A00] | P80404 | ABAT |
| T59045 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P80404 | ABAT |
| T59045 | DI0135 | Epileptic encephalopathy | [ICD-11: 8A62] | P80404 | ABAT |
| T59045 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P80404 | ABAT |
| T59045 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P80404 | ABAT |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T31956 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q07075 | ENPEP |
| T43115 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P08575 | PTPRC |
| T43115 | DI0414 | Transplanted organ/tissue | [ICD-11: QB63] | P08575 | PTPRC |
| T02506 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P03372 | ESR1 |
| T13348 | DI0365 | Retinopathy | [ICD-11: 9B71] | P27695 | APEX1 |
| T13348 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P27695 | APEX1 |
| T94085 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10276 | RARA |
| T94085 | DI0251 | Mature T-cell lymphoma | [ICD-11: 2A90] | P10276 | RARA |
| T84634 | DI0314 | Oesophagitis | [ICD-11: DA24] | O43174 | CYP26A1 |
| T13726 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P19793 | RXRA |
| T13726 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P19793 | RXRA |
| T22839 | DI0024 | Alpha-1-antitrypsin deficiency | [ICD-11: 5C5A] | Q9UNI1 | CELA1 |
| T22839 | DI0065 | Bronchitis | [ICD-11: CA20] | Q9UNI1 | CELA1 |
| T60077 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P28702 | RXRB |
| T82146 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P13631 | RARG |
| T82146 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P13631 | RARG |
| T82146 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P13631 | RARG |
| T82146 | DI0277 | Muscle calcification/ossification | [ICD-11: FB31] | P13631 | RARG |
| T82146 | DI0351 | Psoriasis | [ICD-11: EA90] | P13631 | RARG |
| T46456 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P48443 | RXRG |
| T46456 | DI0232 | Light sensitivity impairment | [ICD-11: 9D45] | P48443 | RXRG |
| T61657 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P10826 | RARB |
| T63170 | DI0201 | Inborn carbohydrate metabolism error | [ICD-11: 5C51] | Q9UJM8 | HAO1 |
| T17067 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P45974 | USP5 |
| T17067 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45974 | USP5 |
| T13259 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P51649 | ALDH5A1 |
| T13259 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P51649 | ALDH5A1 |
| T11615 | DI0054 | Body-focused behaviour disorder | [ICD-11: 6B25] | Q9UPY5 | SLC7A11 |
| T61729 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P13674 | P4HA1 |
| T61729 | DI0413 | Transplant rejection | [ICD-11: NE84] | P13674 | P4HA1 |
| T00890 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P49019 | HCAR3 |
| T00890 | DI0128 | Dyslipidemia | [ICD-11: 5C80-5C81] | P49019 | HCAR3 |
| T00890 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P49019 | HCAR3 |
| T00890 | DI0351 | Psoriasis | [ICD-11: EA90] | P49019 | HCAR3 |
| T97071 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | Q04609 | FOLH1 |
| T97071 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q04609 | FOLH1 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T74937 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P09172 | DBH |
| T74937 | DI0341 | Post-traumatic stress disorder | [ICD-11: 6B40] | P09172 | DBH |
| T42760 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9UBS0 | RPS6KB2 |